Bile acids as a therapy to combat obesity

In a recent publication, DMRG demonstrates that a 2-day intervention with bile acid chenodeoxycholic acid (CDCA) increases brown adipose tissue (BAT) activity together with whole body energy expenditure in healthy humans. Further the involvement of bile acid receptor TGR5 is demonstrated in this human proof-of-concept study. The results have been published in Cell Metabolism.

CDCA_CellMetab